Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Mar-24 5:46 PM View:  | Ambrx Biopharma, Inc. (AMAM) | 07-Mar-24 | Disposition | 48,202 | -- | -- | (100%) 48.2K to 0 | |
| 11-Dec-23 5:15 PM View: | Ambrx Biopharma, Inc. (AMAM) | 11-Dec-23 | Grant | 750,000 | -- | -- | 122% 613.33K to 1.36M | |
| 31-Oct-23 5:00 PM View: | Ambrx Biopharma, Inc. (AMAM) | 27-Oct-23 | Market Sale (Planned) | 50,012 | $9.82 | $491,118.00 | (13%) 392.86K to 342.85K | (< 1%) |
| 28-Apr-23 5:59 PM View: | Ambrx Biopharma Inc. (AMAM) | 26-Apr-23 | Grant | 2,750,000 | -- | -- | 100% 0 to 2.75M | |
| 14-Dec-22 7:21 PM View: | Zyversa Therapeutics, Inc. (ZVSA) | 12-Dec-22 | Acquisition (other) | 1,377,600 | -- | -- | 100% 0 to 1.38M | |
| 02-Jun-22 4:29 PM View: | NexMed Inc. (SEEL) | 01-Jun-22 | Private Purchase | 16,000 | $0.61 | $9,788.80 | 100% 0 to 16.0K | |
| 10-Mar-22 5:31 PM View: | Zyversa Therapeutics, Inc. (ZVSA) | 06-Jan-22 | Acquisition (other) | 42,005 | -- | -- | 100% 0 to 42.01K | |
| 04-May-21 8:00 PM View: | Oncosec Medical Inc (ONCS) | 30-Apr-21 | Market Sale | 3,172 | $4.86 | $15,415.90 | (3%) 99.27K to 96.1K | (4%) |
| 02-Feb-21 8:00 PM View: | Oncosec Medical Inc (ONCS) | 01-Feb-21 | Market Sale | 3,413 | $7.71 | $26,314.20 | (3%) 102.68K to 99.27K | < 1% |
| 03-Nov-20 8:04 PM View: | Oncosec Medical Inc (ONCS) | 02-Nov-20 | Market Sale | 3,280 | $3.79 | $12,431.20 | (3%) 105.96K to 102.68K | (66%) |
| 04-Aug-20 9:21 PM View: | Oncosec Medical Inc (ONCS) | 31-Jul-20 | Market Sale | 3,133 | $4.20 | $13,158.60 | (3%) 109.09K to 105.96K | (49%) |
| 03-Jun-20 9:05 PM View: | Oncosec Medical Inc (ONCS) | 29-May-20 | Grant | 90,580 | -- | -- | 144% 62.99K to 153.57K | |
| 03-Jun-20 9:05 PM View: | Oncosec Medical Inc (ONCS) | 29-May-20 | Payment of Exercise | 44,471 | $2.23 | $99,170.30 | (29%) 153.57K to 109.09K | (181%) |
| 04-May-20 6:07 PM View: | Oncosec Medical Inc (ONCS) | 30-Apr-20 | Market Sale | 3,075 | $1.79 | $5,504.25 | (5%) 66.06K to 62.99K | (253%) |
| 03-Feb-20 8:00 PM View: | Oncosec Medical Inc (ONCS) | 31-Jan-20 | Market Sale | 2,654 | $1.96 | $5,201.84 | (4%) 68.72K to 66.06K | (219%) |
| 01-Nov-19 8:00 PM View: | Oncosec Medical Inc (ONCS) | 31-Oct-19 | Market Sale | 2,128 | $2.16 | $4,596.48 | (3%) 70.84K to 68.72K | (191%) |
| 02-Aug-19 6:00 PM View: | Oncosec Medical Inc (ONCS) | 31-Jul-19 | Payment of Exercise | 2,156 | $2.23 | $4,807.88 | (3%) 73.0K to 70.84K | (184%) |
| 02-May-19 4:15 PM View: | Oncosec Medical Inc (ONCS) | 30-Apr-19 | Payment of Exercise | 21,357 | $0.56 | $12,066.70 | (3%) 751.35K to 729.99K | (11%) |
| 01-Feb-19 9:00 PM View: | Oncosec Medical Inc (ONCS) | 31-Jan-19 | Payment of Exercise | 25,318 | $0.88 | $22,279.80 | (3%) 776.67K to 751.35K | 27% |
| 27-Dec-18 9:00 PM View: | Oncosec Medical Inc (ONCS) | 24-Dec-18 | Grant | 750,000 | -- | -- | 2812% 26.67K to 776.67K | |
| 07-Nov-18 12:08 PM View: | Oncosec Medical Inc (ONCS) | 07-Nov-18 | Market Purchase | 10,000 | $0.91 | $9,100.00 | 60% 16.67K to 26.67K | (31%) |
| 06-Feb-18 9:15 AM View: | Oncosec Medical Inc (ONCS) | 05-Feb-18 | Private Purchase | 16,667 | $1.50 | $25,000.50 | 100% 0 to 16.67K | |
| 03-Jul-17 4:30 PM View: | Advaxis Inc. (ADXS) | 30-Jun-17 | Grant | 742 | $6.49 | $4,815.58 | < 1% 617.61K to 618.35K | (99%) |
| 20-Jun-17 6:30 PM View: | Advaxis Inc. (ADXS) | 19-Jun-17 | Grant | 177,102 | -- | -- | 40% 440.51K to 617.61K | |
| 01-Jun-17 4:30 PM View: | Advaxis Inc. (ADXS) | 31-May-17 | Grant | 421 | $8.07 | $3,397.47 | < 1% 440.09K to 440.51K | (99%) |
| 01-May-17 5:31 PM View: | Advaxis Inc. (ADXS) | 01-May-17 | Grant | 142,996 | -- | -- | 48% 297.09K to 440.09K | |
| 01-May-17 5:31 PM View: | Advaxis Inc. (ADXS) | 28-Apr-17 | Grant | 349 | $8.56 | $2,987.44 | < 1% 296.74K to 297.09K | (100%) |
| 03-Apr-17 4:36 PM View: | Advaxis Inc. (ADXS) | 31-Mar-17 | Grant | 365 | $8.17 | $2,982.05 | < 1% 296.38K to 296.74K | (100%) |
| 01-Mar-17 4:30 PM View: | Advaxis Inc. (ADXS) | 28-Feb-17 | Grant | 490 | $8.79 | $4,307.10 | < 1% 295.99K to 296.48K | (100%) |
| 01-Mar-17 4:30 PM View: | Advaxis Inc. (ADXS) | 28-Feb-17 | Payment of Exercise | 104 | $8.79 | $914.16 | (< 1%) 296.48K to 296.38K | 100% |
| 02-Feb-17 4:30 PM View: | Advaxis Inc. (ADXS) | 31-Jan-17 | Grant | 466 | $8.96 | $4,175.36 | < 1% 295.62K to 296.09K | (100%) |
| 02-Feb-17 4:30 PM View: | Advaxis Inc. (ADXS) | 31-Jan-17 | Payment of Exercise | 97 | $8.96 | $869.12 | (< 1%) 296.09K to 295.99K | 100% |
| 03-Jan-17 5:29 PM View: | Advaxis Inc. (ADXS) | 30-Dec-16 | Grant | 792 | $7.16 | $5,670.72 | < 1% 295.02K to 295.81K | (99%) |
| 03-Jan-17 5:29 PM View: | Advaxis Inc. (ADXS) | 30-Dec-16 | Payment of Exercise | 192 | $7.16 | $1,374.72 | (< 1%) 295.81K to 295.62K | 99% |
| 01-Dec-16 4:33 PM View: | Advaxis Inc. (ADXS) | 30-Nov-16 | Grant | 455 | $8.31 | $3,781.05 | < 1% 294.66K to 295.11K | (100%) |
| 01-Dec-16 4:33 PM View: | Advaxis Inc. (ADXS) | 30-Nov-16 | Payment of Exercise | 89 | $8.31 | $739.59 | (< 1%) 295.11K to 295.02K | 100% |
| 02-Nov-16 4:40 PM View: | Advaxis Inc. (ADXS) | 02-Nov-16 | Market Sale | 8,240 | $8.32 | $68,556.80 | (3%) 302.9K to 294.66K | 100% |
| 02-Nov-16 4:40 PM View: | Advaxis Inc. (ADXS) | 31-Oct-16 | Grant | 467 | $8.09 | $3,778.03 | < 1% 302.66K to 303.13K | (100%) |
| 02-Nov-16 4:40 PM View: | Advaxis Inc. (ADXS) | 31-Oct-16 | Payment of Exercise | 231 | $8.09 | $1,868.79 | (< 1%) 303.13K to 302.9K | 100% |
| 04-Oct-16 6:21 PM View: | Advaxis Inc. (ADXS) | 30-Sep-16 | Grant | 354 | $10.69 | $3,784.26 | < 1% 302.36K to 302.71K | (100%) |
| 04-Oct-16 6:21 PM View: | Advaxis Inc. (ADXS) | 30-Sep-16 | Payment of Exercise | 50 | $10.69 | $534.50 | (< 1%) 302.71K to 302.66K | 100% |
| 01-Sep-16 4:30 PM View: | Advaxis Inc. (ADXS) | 31-Aug-16 | Grant | 328 | $11.53 | $3,781.84 | < 1% 302.07K to 302.4K | (100%) |
| 01-Sep-16 4:30 PM View: | Advaxis Inc. (ADXS) | 31-Aug-16 | Payment of Exercise | 46 | $11.53 | $530.38 | (< 1%) 302.4K to 302.36K | 100% |
| 01-Aug-16 4:30 PM View: | Advaxis Inc. (ADXS) | 29-Jul-16 | Grant | 1,133 | $8.34 | $9,449.22 | < 1% 309.77K to 310.9K | (100%) |
| 01-Aug-16 4:30 PM View: | Advaxis Inc. (ADXS) | 29-Jul-16 | Payment of Exercise | 562 | $8.34 | $4,687.08 | (< 1%) 310.9K to 310.34K | 100% |
| 01-Jul-16 4:30 PM View: | Advaxis Inc. (ADXS) | 30-Jun-16 | Grant | 1,752 | $8.09 | $14,173.70 | < 1% 308.57K to 310.32K | (100%) |
| 01-Jul-16 4:30 PM View: | Advaxis Inc. (ADXS) | 30-Jun-16 | Payment of Exercise | 551 | $8.09 | $4,457.59 | (< 1%) 310.32K to 309.77K | 100% |
| 01-Jun-16 4:31 PM View: | Advaxis Inc. (ADXS) | 31-May-16 | Grant | 1,020 | $9.26 | $9,445.20 | < 1% 307.82K to 308.84K | (100%) |
| 01-Jun-16 4:31 PM View: | Advaxis Inc. (ADXS) | 31-May-16 | Payment of Exercise | 268 | $9.26 | $2,481.68 | (< 1%) 308.84K to 308.57K | 100% |
| 02-May-16 4:31 PM View: | Advaxis Inc. (ADXS) | 02-May-16 | Market Sale | 8,237 | $7.51 | $61,859.90 | (3%) 316.05K to 307.82K | 99% |